[236 Pages] The global ePharmacy market is projected to expand at 14.3% CAGR to reach a market valuation of US$ 351.9 billion by the end of 2033, up from the US$ 81.5 billion recorded for 2022.
“The growth of the global ePharmacy market is being driven by pharmacies efficiency in providing affordable medicinal products as well as increased e-commerce penetration”
| Attribute | Details |
|---|---|
| ePharmacies Market Size (2023) | US$ 92.4 Billion |
| Forecasted Market Value (2033) | US$ 351.9 Billion |
| Value CAGR (2023 to 2033) | 14.3% |
| Collective Value Share: Top 5 Countries (2022) | 58.4% |
| Key Market Players | Netmeds Marketplace Ltd, EasyMedico, Medlife, Amazon. Inc, Apotek, The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Express Scripts, CVS Health, Optum, Inc., L Rowland & Co (Retail) Ltd, Zur Rose Group AG, McKesson Corporation, SHOP-APOTHEKE EUROPE N.V., UK Meds Direct Ltd., Walgreens Boots Alliance, Inc., DocMorris |
There is a rising demand for mail-order pharmaceuticals as e-commerce and internet use become more widespread. Worldwide, many online pharmacies, also called ePharmacies, offer doorstep delivery and medication dispensing for prescription and over-the-counter drugs. Since the introduction of ePharmacy, patients no longer need to visit the pharmacist, and ease of ordering over various supplier platforms has resulted in market development.
Leading ePharmacy firms also provide medications at lower costs than conventional brick-and-mortar pharmacies. As a result of more significant investment by e-commerce big players in the healthcare sector, the ePharmacy market is anticipated to grow at a significant rate over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The ePharmacies market expanded at a CAGR of 12.9% during the historical period (2017 to 2022) and reached a market value of US$ 81.4 billion in 2022.
A large patient pool worldwide chose doorstep delivery of medical supplies because of the unavailability of some prescription medicines at retail pharmacy stores. ePharmacies reduce the need for senior citizens and people with chronic illnesses to rely on other parties to get their medications and medical supplies. Likewise, increased internet usage and awareness are anticipated to increase ePharmacy market sales.
The growing global accessibility of the internet and online commercial platforms and their products has provided various lucrative opportunities for ePharmacy to build a large customer base in developed as well as growing economies. Furthermore, youngsters of the current population heavily rely on online shopping for products like cosmetics/cosmeceuticals and over-the-counter pharmaceuticals.
The rapid development of the internet, the rise of digital health or eHealth, the transition from direct doctor-patient interactions toward self-diagnosis, consumer experience with online purchases, the simplicity of mail-order commerce, and distance selling all contribute to the growth of the online pharmacy market.
H1-H2 Update
| Market Statistics | Details |
|---|---|
| Jan–Jun (H1), 2021 (A) | 10.89% |
| Jul–Dec (H2), 2021 (A) | 14.09% |
| Jan–Jun (H1),2022 Projected (P) | 10.37% |
| Jan–Jun (H1),2022 Outlook (O) | 11.19% |
| Jul–Dec (H2), 2022 Outlook (O) | 14.66% |
| Jul–Dec (H2), 2022 Projected (P) | 13.71% |
| Jan–Jun (H1), 2023 Projected (P) | 11.21% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 82↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 30↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 94↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 56↑ |
The growth of the ePharmacy market is being hampered by the existence of fraudulent online pharmacies and counterfeit products. Secondly, since these unauthorized pharmacies sell pharmaceuticals that the FDA has not approved, there is a higher chance that one will get contaminated, fake medications from them that contain the incorrect active components.
Principal Consultant
Smartphone adoption is expanding, which is helping the ePharmacy Market grow. The adoption rate of smartphones was around 65.0% in 2019 and is predicted to reach 80.0% by 2025, according to The Mobile Economy 2020.
The expanding healthcare industry and the high operating expenses have made it necessary to use ePharmacy platforms to reduce operational costs. Demand for numerous healthcare products, especially medications, is rising as chronic conditions become more common. This represents a greater opportunity of online modes of drug procurement worldwide.
Over the course of the forecast period, the market is anticipated to grow as more e-pharmacies are established in emerging nations.
An increase in internet consumers, more accessible access to web-based and online services, and an increase in the use of e-prescriptions in healthcare facilities are all factors contributing to the growth of the e-pharmacy market.
For instance, Phoenix UK acquired Co-op Health in March 2021, a digital prescription service that enables people to order medication through an application for pickup at a nearby pharmacy or home delivery. Due to the increase in service usage and expansion, such acquisitions in the e-pharmacy market are anticipated to fuel market growth.
| Country | USA |
|---|---|
| Market Share (2023) | 34.6% |
| Market Share (2033) | 44.0% |
| BPS Analysis | 938 |
| Country | China |
|---|---|
| Market Share (2023) | 6.6% |
| Market Share (2033) | 5.4% |
| BPS Analysis | -126 |
| Country | Germany |
|---|---|
| Market Share (2023) | 6.3% |
| Market Share (2033) | 7.4% |
| BPS Analysis | 102 |
| Country | Australia |
|---|---|
| Market Share (2023) | 5.9% |
| Market Share (2033) | 5.8% |
| BPS Analysis | -4 |
| Country | Japan |
|---|---|
| Market Share (2023) | 5.3% |
| Market Share (2033) | 5.1% |
| BPS Analysis | -15 |
The United States is set to hold a share of around 34.6% of the global ePharmacy Market in 2023.
Some of the key drivers driving the growth of the USA market are the rising utilization of e-commerce platforms, an ageing population, and developed healthcare infrastructure. Additionally, the majority of USA citizens are involved with ePharmacy and the evolving tendency toward the direct-to-patient approach.
The consumer-friendly online experiences made possible by the digital world as well as other advanced services are further fueling the expansion of the USA market as a whole. As a result, in December 2020, the cardiovascular pharmaceutical company, Medicure Inc., declared that it formalized a deal to acquire Marley Drug, Inc. through its wholly-owned USA subsidiary, Medicure Pharma Inc.
Germany is set to hold a share of 6.3% of the global market in 2023.
The ePharmacy market trend is anticipated to be positively impacted by the general population's reliance on online delivery of consumer products including OTC healthcare products such as vitamin pills, supplements, cosmetics, and others. Online pharmaceutical procurement is anticipated to rise in the Germany as a result of an increase in the number of patients using home care services and treatments as a result of excessive healthcare expenditure in hospitals.
China is set to hold a share of 6.6% of the global market in 2023.
In China, the e-pharmacy industry is evolving rapidly due to new rules and the entry of new competitors. Hospitals and governments are collaborating with online pharmacies on pilot projects to let patients order medications online with valid prescriptions. China's enormous population indicates numerous patients suffering from chronic diseases, and there is also an increasing public awareness of online pharmacies, all these factors are expected to uplift the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Over-the-counter product segments are expected to hold a market share of 71.4% in 2023 globally.
As the general public becomes more informed and aware of the primary treatment for common ailments, the need for OTC medications will increase. Sales in the ePharmacy market will be driven by the availability of a large selection of over-the-counter drugs for numerous common disorders like the cold and flu. Additionally, a legal framework that promotes transitioning from Rx to OTC will boost category sales growth.
On the other hand, consumers are increasingly choosing OTC drugs over prescription drugs due to their increased affordability and accessibility. The factors above will increase the number of products available in the ePharmacy market.
To gain a competitive edge and solidify their market positions, market participants are exploring a number of growth strategies. The worldwide ePharmacy market is expected to have significant growth due to increasing consumer demands. Online retail platforms' easy access to regulated prescription drugs such as stimulants, painkillers, and tranquillizing hypnotics is indirectly contributing to market growth.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the ePharmacy market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, Asia-Pacific excluding Japan, and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product and region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
The ePharmacy market is valued at US$ 92.4 billion in 2023.
The ePharmacy market is estimated to surpass US$ 351.9 billion by 2033.
The ePharmacy market is projected to experience a CAGR of 14.3% through 2033.
The United States ePharmacy market commands 34.6% of global value in 2023.
The ePharmacy market attained a value of US$ 81.4 billion by 2022, with a CAGR of 12.9%
1. Executive Summary | ePharmacy Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Growing Popularity of Market
4.1. A New Generation adopting solutions
4.2. Branded products at low cost are behind the Market growth
5. market is Changing- Training Industry
5.1. Evolution and Challenges in the Organization
5.2. Delivery of in Short Time Slots
6. Key Market Trends
6.1. Key Trends Impacting the Market
6.2. Formulation and Product Development Trends
7. Key Success Factors
7.1. Top Companies
7.2. PESTLE Analysis of Market
7.3. Porter’s Five Force
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Organization spending on R&D
8.1.2. Pharmaceutical Industry Contribution to GDP
8.1.3. Outlook
8.1.4. Outbreak of Covid-19 Pandemic
8.1.5. Economic Instability
8.1.6. Impact of Online Sale
8.2. Forecast Factors - Relevance & Impact
8.2.1. Global Industry Assessment
8.2.2. Global Services Market
8.2.3. Global Pricing Assessment
8.2.4. Global Industry outlook
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
9. Global Market Demand (in Value US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
9.2. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis, by Product, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Product, 2023 to 2033
10.3.1. Over the Counter Product
10.3.2. Prescription Medicine
10.4. Market Attractiveness Analysis, by Product
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis, by Region, 2017 to 2022
11.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. The Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis, by Region
12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
12.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
12.3.1. By Country
12.3.1.1. USA
12.3.1.2. Canada
12.3.2. By Product
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.5. Market Trends
12.6. Drivers and Restraints - Impact Analysis
12.7. Country Level Analysis & Forecast
12.7.1. USA Market Analysis
12.7.1.1. Introduction
12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
12.7.1.2.1. By Product
12.7.2. Canada Market Analysis
12.7.2.1. Introduction
12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
12.7.2.2.1. By Product
13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
13.3.1. By Country
13.3.1.1. Mexico
13.3.1.2. Brazil
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.5. Market Trends
13.6. Drivers and Restraints - Impact Analysis
13.7. Country Level Analysis & Forecast
13.7.1. Mexico Market Analysis
13.7.1.1. Introduction
13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
13.7.1.2.1. By Product
13.7.2. Brazil Market Analysis
13.7.2.1. Introduction
13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
13.7.2.2.1. By Product
13.7.3. Argentina Market Analysis
13.7.3.1. Introduction
13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
13.7.3.2.1. By Product
14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. United Kingdom
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. Germany Market Analysis
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
14.7.1.2.1. By Product
14.7.2. Italy Market Analysis
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
14.7.2.2.1. By Product
14.7.3. France Market Analysis
14.7.3.1. Introduction
14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
14.7.3.2.1. By Product
14.7.4. United Kingdom Market Analysis
14.7.4.1. Introduction
14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
14.7.4.2.1. By Product
14.7.5. Spain Market Analysis
14.7.5.1. Introduction
14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
14.7.5.2.1. By Product
14.7.6. BENELUX Market Analysis
14.7.6.1. Introduction
14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
14.7.6.2.1. By Product
14.7.7. Russia Market Analysis
14.7.7.1. Introduction
14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
14.7.7.2.1. By Product
15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market End User (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. China Market Analysis
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
15.7.1.2.1. By Product
15.7.2. Japan Market Analysis
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
15.7.2.2.1. By Product
15.7.3. South Korea Market Analysis
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
15.7.3.2.1. By Product
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Malaysia
16.3.1.4. Thailand
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
16.7.1. India Market Analysis
16.7.1.1. Introduction
16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
16.7.1.2.1. By Product
16.7.2. Indonesia Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
16.7.2.2.1. By Product
16.7.3. Malaysia Market Analysis
16.7.3.1. Introduction
16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
16.7.3.2.1. By Product
16.7.4. Thailand Market Analysis
16.7.4.1. Introduction
16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
16.7.4.2.1. By Product
17. Oceania Market 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
17.7.1. Australia Market Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
17.7.1.2.1. By Product
17.7.2. New Zealand Market Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
17.7.2.2.1. By Product
18. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) Trend Analysis, by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Value (US$ Million) Analysis and Forecast, 2023 to 2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Product
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
18.7.1. GCC Countries Market Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
18.7.1.2.1. By Product
18.7.2. Türkiye Market Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
18.7.2.2.1. By Product
18.7.3. South Africa Market Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
18.7.3.2.1. By Product
18.7.4. North Africa Market Analysis
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
18.7.4.2.1. By Product
19. Market Structure Analysis
19.1. Market Analysis, by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Netmeds Marketplace Ltd.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Key Financials
20.3.1.5. SWOT Analysis
20.3.1.6. Strategy Overview
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. EasyMedico
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Key Financials
20.3.2.5. SWOT Analysis
20.3.2.6. Strategy Overview
20.3.2.6.1. Marketing Strategy
20.3.2.6.2. Product Strategy
20.3.2.6.3. Channel Strategy
20.3.3. Medlife
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Key Financials
20.3.3.5. SWOT Analysis
20.3.3.6. Strategy Overview
20.3.3.6.1. Marketing Strategy
20.3.3.6.2. Product Strategy
20.3.3.6.3. Channel Strategy
20.3.4. Amazon. Inc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Key Financials
20.3.4.5. SWOT Analysis
20.3.4.6. Strategy Overview
20.3.4.6.1. Marketing Strategy
20.3.4.6.2. Product Strategy
20.3.4.6.3. Channel Strategy
20.3.5. Apotek
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Key Financials
20.3.5.5. SWOT Analysis
20.3.5.6. Strategy Overview
20.3.5.6.1. Marketing Strategy
20.3.5.6.2. Product Strategy
20.3.5.6.3. Channel Strategy
20.3.6. The Kroger Co.
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Key Financials
20.3.6.5. SWOT Analysis
20.3.6.6. Strategy Overview
20.3.6.6.1. Marketing Strategy
20.3.6.6.2. Product Strategy
20.3.6.6.3. Channel Strategy
20.3.7. Walgreen Co.
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Key Financials
20.3.7.5. SWOT Analysis
20.3.7.6. Strategy Overview
20.3.7.6.1. Marketing Strategy
20.3.7.6.2. Product Strategy
20.3.7.6.3. Channel Strategy
20.3.8. Giant Eagle, Inc.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Key Financials
20.3.8.5. SWOT Analysis
20.3.8.6. Strategy Overview
20.3.8.6.1. Marketing Strategy
20.3.8.6.2. Product Strategy
20.3.8.6.3. Channel Strategy
20.3.9. Walmart
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Key Financials
20.3.9.5. SWOT Analysis
20.3.9.6. Strategy Overview
20.3.9.6.1. Marketing Strategy
20.3.9.6.2. Product Strategy
20.3.9.6.3. Channel Strategy
20.3.10. Express Scripts
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Key Financials
20.3.10.5. SWOT Analysis
20.3.10.6. Strategy Overview
20.3.10.6.1. Marketing Strategy
20.3.10.6.2. Product Strategy
20.3.10.6.3. Channel Strategy
20.3.11. CVS Health
20.3.11.1. Overview
20.3.11.2. Product Portfolio
20.3.11.3. Sales Footprint
20.3.11.4. Key Financials
20.3.11.5. SWOT Analysis
20.3.11.6. Strategy Overview
20.3.11.6.1. Marketing Strategy
20.3.11.6.2. Product Strategy
20.3.11.6.3. Channel Strategy
20.3.12. Optum, Inc.
20.3.12.1. Overview
20.3.12.2. Product Portfolio
20.3.12.3. Sales Footprint
20.3.12.4. Key Financials
20.3.12.5. SWOT Analysis
20.3.12.6. Strategy Overview
20.3.12.6.1. Marketing Strategy
20.3.12.6.2. Product Strategy
20.3.12.6.3. Channel Strategy
20.3.13. L Rowland & Co (Retail) Ltd
20.3.13.1. Overview
20.3.13.2. Product Portfolio
20.3.13.3. Sales Footprint
20.3.13.4. Key Financials
20.3.13.5. SWOT Analysis
20.3.13.6. Strategy Overview
20.3.13.6.1. Marketing Strategy
20.3.13.6.2. Product Strategy
20.3.13.6.3. Channel Strategy
20.3.14. Zur Rose Group AG
20.3.14.1. Overview
20.3.14.2. Product Portfolio
20.3.14.3. Sales Footprint
20.3.14.4. Key Financials
20.3.14.5. SWOT Analysis
20.3.14.6. Strategy Overview
20.3.14.6.1. Marketing Strategy
20.3.14.6.2. Product Strategy
20.3.14.6.3. Channel Strategy
20.3.15. McKesson Corporation
20.3.15.1. Overview
20.3.15.2. Product Portfolio
20.3.15.3. Sales Footprint
20.3.15.4. Key Financials
20.3.15.5. SWOT Analysis
20.3.15.6. Strategy Overview
20.3.15.6.1. Marketing Strategy
20.3.15.6.2. Product Strategy
20.3.15.6.3. Channel Strategy
20.3.16. SHOP-APOTHEKE EUROPE N.V.
20.3.16.1. Overview
20.3.16.2. Product Portfolio
20.3.16.3. Sales Footprint
20.3.16.4. Key Financials
20.3.16.5. SWOT Analysis
20.3.16.6. Strategy Overview
20.3.16.6.1. Marketing Strategy
20.3.16.6.2. Product Strategy
20.3.16.6.3. Channel Strategy
20.3.17. UK Meds Direct Ltd.
20.3.17.1. Overview
20.3.17.2. Product Portfolio
20.3.17.3. Sales Footprint
20.3.17.4. Key Financials
20.3.17.5. SWOT Analysis
20.3.17.6. Strategy Overview
20.3.17.6.1. Marketing Strategy
20.3.17.6.2. Product Strategy
20.3.17.6.3. Channel Strategy
20.3.18. Walgreens Boots Alliance, Inc.
20.3.18.1. Overview
20.3.18.2. Product Portfolio
20.3.18.3. Sales Footprint
20.3.18.4. Key Financials
20.3.18.5. SWOT Analysis
20.3.18.6. Strategy Overview
20.3.18.6.1. Marketing Strategy
20.3.18.6.2. Product Strategy
20.3.18.6.3. Channel Strategy
20.3.19. DocMorris
20.3.19.1. Overview
20.3.19.2. Product Portfolio
20.3.19.3. Sales Footprint
20.3.19.4. Key Financials
20.3.19.5. SWOT Analysis
20.3.19.6. Strategy Overview
20.3.19.6.1. Marketing Strategy
20.3.19.6.2. Product Strategy
20.3.19.6.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
ePharmacy Market
